Prime Medicine, Inc. (PRME) Balance Sheet
As of 2026-06-30 (10-Q), Prime Medicine, Inc. (PRME) reported total assets of $249.0M, total liabilities of $209.2M and shareholders' equity of $39.8M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $47.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PRMEPrime Medicine, Inc.Follow PRME — free
—
Price chart with a free account
- Market cap
- 665.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 30 Oct, in 5 days
| Line | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|
| Cash and equivalents | 187.6 | 41.6 | 182.5 | 63.0 | 47.5 | |
| Short-term investments | 98.5 | — | — | 114.6 | 47.6 | |
| Current assets | 296.6 | 143.0 | 211.9 | 181.3 | 96.8 | |
| Total assets | 360.3 | 193.9 | 297.5 | 342.7 | 249.0 | |
| Current liabilities | 26.7 | 56.4 | 38.0 | 37.4 | 31.7 | |
| Total liabilities | 44.0 | 60.8 | 144.4 | 221.9 | 209.2 | |
| Shareholders' equity | 316.3 | 133.1 | 153.1 | 120.9 | 39.8 |
USD millions · SEC XBRL
Prime Medicine, Inc. — questions
- How much cash does Prime Medicine, Inc. have?
- $47.5M in cash and cash equivalents as of 2026-06-30.
- What are Prime Medicine, Inc.'s total assets?
- $249.0M as of 2026-06-30.
- What is Prime Medicine, Inc.'s shareholders' equity?
- $39.8M as of 2026-06-30.
Every figure on this page comes from Prime Medicine, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.